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ABSTRACT 
 
Parasites and pathogens are a source of diseases that can affect the health, behavior and reproductive fitness 
of an individual. The study of animal self-medication as a science is relatively new, but traditional societies 
have long looked to animals for clues to nature’s medicine cabinet.  Evidence of self-medication is widespread 
throughout the animal kingdom.  To date, research has classified health maintenance and self-medicative 
behaviors into five levels: 1) ‘sick behaviors’; 2) behavioral avoidance or reduction of the possibility for 
disease transmission; 3) dietary selection of items with a preventative or health maintenance effect; 4) 
ingestion of a substance for the curative treatment of a disease or the symptoms thereof, and; 5) application of 
a substance to the body or a living space for the treatment or control of vectors or external health condition. 
Among the groups of animals studied to date, primates have provided the most details for level 3 and 4 
behaviors, exemplified by such diverse dietary selection and behaviors as bitter pith chewing and whole leaf 
swallowing behaviors, used directly in response to increased levels of parasite infection. 
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“The adaptive value of warding off predators, whether larger and faster, or smaller and stealthier 
then oneself should not be surprising, yet science has been slow to recognize the ability of animals 
to avoid, suppress or eliminate parasites and other agents of disease that equally compromise their 
health and wellbeing. While it appears that an awareness of and even practical applications based 
on the behavior of animals as a source of medicinal wisdom has been around for much of our own 
species history, science has been slow to appreciate this.”  Huffman 2015a 
 
1. INTRODUCTION 
 
The study of animal self-medication as a science 
is relatively recent, although history tells us that 
humans have traditionally long looked to 
animals as a source of medicinal knowledge 
(Engel, 2002; Huffman, 2002; 2007a).  Not only 
have humans learned from watching sick wild 
animals, because we share the same 
evolutionary history, possess a common 
physiology and have lived together under 
similar environmental condition for much of our 
species history, it can be argued that we have 
inherited many of the same ways to combat 
common diseases in the environment (Huffman, 
2015a).  In support of this notion, recent 
archeological and biochemical evidence 
suggests that a close extinct relative in our 
lineage, Homo neanderthalensis, also used 
medicinal plants that are still in use today by our 
own species (Hardy et al., 2012; 2013; Huffman, 
2016). 
 
Research in the field of self-medication is 
devoted to understanding how animals respond 
to threats to their health and how these behaviors 
are transmitted across generations.  It has 
provided a “bio-rational” for the exploration and 
exploitation of novel secondary plant 
compounds and new insights into how they can 
be used for the management of health in humans 
and livestock (Huffman et al., 1996; 1998; Krief 
et al., 2005; 2006; Petroni et al., 2016).  At the 
proximate level, self-medication may be driven 
by the individual’s ‘need’ to maintain 
physiological homeostasis; that is to feel well 
(Foitova et al., 2009; Forbey et al., 2009).   
 
To date, the majority of evidence for self-
medication in animals is about ways in which 
they deal with parasite or pathogen induced  
 
illness, but there is no reason why it should be 
restricted to such illnesses alone (Huffman, 
1997; 2007b).  As all animals experience illness, 
it should come as no surprise if we find evidence 
in virtually every living species today.  The 
ability of a species to defend itself against life-
threatening disease provides a significant 
adaptive advantage and is predicted to occur 
throughout the animal kingdom.   
 
Much work exists describing the diversity of 
host-parasite relationships in the animal 
kingdom (Clayton & Moore, 1997).  Some 
parasitic infections seem to go unnoticed by the 
hosts.  In other cases, when homeostasis is 
disrupted or threatened, it is in the best interest 
of the host to actively respond to alleviate 
discomfort.  Regardless of the illness, there are 
four basic requirements for demonstrating self-
medication: i) identify the disease or 
symptom(s) being treated; ii) distinguish the use 
of a therapeutic agent from that of everyday food 
items and or ‘medicinal foods’; iii) demonstrate 
a positive change in health condition following 
self-medicative behavior, and; iv) provide 
evidence for plant activity and or direct 
pharmacological analysis of compounds 
extracted from these therapeutic agents 
(Huffman, 1997).  
 
Given our current level of understanding, 
response to illness, either as health maintenance 
or direct self-medicative behavior, can be 
classified into five levels  (Huffman, 1994; 
2004): 1) ‘sick behaviors’ (lethargy, depression, 
anorexia, reduction in grooming, behavioral 
fever, basking behavior; 2) behavioral 
avoidance or reduction of the possibility for 
disease transmission (avoidance of feces 
contaminated food, water, substrates); 3) dietary 
selection of items with a preventative or health 
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maintenance effect (items eaten routinely in 
small amounts or on a limited basis); 4) 
ingestion of a substance for the curative 
treatment of a disease or the symptoms thereof 
(use of toxic or biologically active items at low 
frequency or in small amounts, having little no 
nutritional value), and; 5) application of a 
substance to the body or a living space for the 
treatment or control of vectors or external 
health condition.   
 
Behaviors to be focused on here fall within 
levels 3 and 4.  In general terms, level 3 includes 
passive dietary prophylaxis or the consumption 
of ‘medicinal foods’ as health maintenance 
behavior.  Emphasis is put on the passive nature 
of such behavior, since prophylactic treatment 
implies intentionality and an understanding of 
both the cause and prevention of illness.  So far, 
this has not been demonstrated in animals, so 
these dietary choices are expected to be based on 
some immediate feedback.   
 
Level 4 includes therapeutic behaviors such as 
the extraction and ingestion of 
pharmacologically active substances from plants 
or the peculiar ingestion of plants without 
nutritional gain.  This necessarily requires some 
level of awareness of wellness and discomfort 
and the ability to respond with behaviors that 
bring about positive change in one’s condition. 
Evidence for self-medication at these two levels 
has been found across the animal kingdom, with 
homologous behaviors appearing in 
phylogenetically distant taxa (e.g. swallowing of 
whole leaves for the expulsion of tapeworms and 
nodule worms in chimpanzees, gorillas, 
bonobos, gibbons, and brown bear, snow geese, 
civets Huffman, 1997; also see below).  The 
diversity of potentially self-medicating species 
recognized thus far reflects the common need to 
prevent, suppress or cure disease, as mentioned 
above.  Current evidence suggest that for insects, 
self-medication may be operated entirely by 
innate mechanisms (Bernays & Singer, 2005), 
while for some higher vertebrates like 
chimpanzees, important aspects of self-
medication, such as what plant species and when 
and how to ingest it, appear to be acquired and 
transmitted from generation to generation via 
socially biased learning and maintained in the 
group as culture (Huffman & Hirata, 2004; 
Huffman et al., 2010). 
 
 
2. DIETARY SELECTION OR PASSIVE 
DISEASE PREVENTION? 
 
2.1. Medicinal food 
 
For energy, growth, general maintenance, and 
reproduction the selection a proper diet is very 
important.  Typically one thinks of animal 
feeding strategies as being based on finding and 
consuming the most essential nutritional 
elements that is carbohydrates, fats, proteins and 
vitamins and while at the same time avoiding the 
negative impact of secondary metabolites in 
plants.  For plants, these secondary metabolites 
protect them from over predation from an array 
of herbivores (insect, vertebrates) that prey upon 
them by reducing palatability and / or 
digestibility (Glander, 1982).  Nonetheless, this 
does not necessarily prevent some animals from 
actually benefiting from these defense 
compounds.  Adult danaine butterflies store 
bitter and toxic pyrrolizidine alkaloids in their 
bodies for defense against predators and males 
depend on them as a precursor for the 
biosynthesis of a pheromone component needed 
for courtship.  The wooly bear caterpillars of the 
tiger moth (Platyprepia virginalis) protect 
themselves from the fatal effects of tachinid 
parasitoid wasp larvae (Thelaira americana) 
infection by changing their diet from innocuous 
lupine (Lupinus arboreus) to the toxic alkaloid 
abundant hemlock (Conium maculatum) if they 
become infected.  The alkaloids may not kill the 
developing parasite within the caterpillar, but it 
does allow the caterpillar to survive such an 
infection.  Studying these kinds of tri-trophic 
interactions (insect host, plant, parasite) can 
surely help to better understand the foundations 
for the evolution of self-medication in higher 
vertebrates (Bernays & Singer, 2005). 
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In 1997, I introduced the concept of medicinal 
foods to primatology, adding an extra element of 
passive disease prevention based on the 
presence of plants in the diet that containing 
noticeable bioactive properties.  This term was 
borrowed from the human 
ethnopharmacological literature (Etkin, 1996).   
For example, among the Hausa peoples of 
Nigeria, 30% of the wild plant food species are 
also used as medicine.  Interestingly, 89% of the 
species used by these people to treat symptoms 
of malaria are also used in a dietary context 
(Etkin & Ross, 1983).  Many food items eaten 
by primates and other mammals also contain a 
variety of secondary metabolites with medicinal 
properties (roughly 15~25% of any populations 
food plant species list), suggesting that animals 
may benefit from the periodic ingestion, in small 
amounts, of these plants (Huffman, 1997; 
Huffman & MacIntosh, 2012; Krief et al., 2006; 
MacIntosh & Huffman, 2010; Mukherjee et al., 
2011). 
 
2.2. Nutrient poor items 
 
Some other interesting items are found in the 
diets of many primate species.  Bark and wood 
are by nature highly fibrous, heavily lignified, 
sometimes toxic, relatively indigestible and 
nutrient poor.  While the list of plant species 
whose bark is ingested by primates is long, little 
is actually known about their contribution to the 
diet and general health (Huffman, 1997).  
Sodium has been suggested to be the reason why 
gorillas in the Impenetrable Forest and 
chimpanzees in the Budongo Forest of Uganda 
to consume large quantities of dead wood 
(Reynolds et al., 2009; Rothman et al., 2006).  
At Mahale in Tanzania, chimpanzees also 
infrequently ingest the bark and wood of several 
plant species.   
 
The bark of Pycnanthus angolensis (Welw.) 
Warb. (Myristicaceae) ingested by chimpanzees 
at Mahale is used by West Africans as a 
purgative, laxative, digestive tonic, emetic and 
reliever of toothaches.  Chimpanzees at Gombe 
in western Tanzania occasionally eat the bark of 
Entada abyssinica (Mimosaceae).  In Ghana, the 
bark is used for diarrhea and as an emetic.  The 
bark of Gongronema latifolium 
(Asclepiadaceae) occasionally eaten by 
chimpanzees at Bossou in Guinea, is extremely 
bitter, and the stems are used by some West 
Africans as a purge for colic, stomach pains and 
symptoms connected with intestinal parasite 
infection (Huffman, 1997). 
 
2.3. Hallucinogens and stimulants 
 
Stories of insects, birds and mammals under the 
influence of fermented fruit or other plant 
material are widespread in wildlife lore and 
literature around the world, but few examples 
have been documented scientifically. One 
example from Africa stands out and is perhaps 
the best scientifically documented hallucinogen 
ingested by animals.  The plant is Tabernanthe 
iboga, (Apocynaceae), a shrub first described in 
1889 (Dubois, 1955; Harrison, 1968).  
  
Today, T. iboga is still used in religious rituals 
in Cameroon.  Indigenous forest hunter 
gatherers reportedly discovered the 
hallucinogenic properties of this plant by 
watching gorillas, wild boars and porcupines 
digging up and eating the roots, afterwards going 
into a wild frenzy, running about as if being 
chased by some frightening animal.   
 
The hallucinogenic affect of this plant was 
demonstrated in the early 1900’s and later 
replicated in the 1950’s by pharmacological 
tests carried out on animals in the laboratory.  
More recently, the plant was under investigation 
in the US as an alternative for methadone, a 
standard treatment for drug addicts (Dubois, 
1955; Harrison, 1968).  
  
A complete review of the gorilla diet literature 
uncovered many well-known medicinal plants 
with well-documented stimulatory, cardiotonic 
and hallucinogenic properties (Cousins & 
Huffman, 2002).  Gorillas utilize many species 
of Kola (Cola) (Sterculiaceae) particularly for 
their seeds, including Cola nitida, C. 
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pachycarpa and C. rostrata.  The seeds of C. 
pachycarpa contain such natural products as 
caffeine and theobromine.  The amino acid 
content in the nuts of Kola suggests weak protein 
levels, which suggests that gorillas obtain 
primarily caffeine from the fruits and seeds 
(Cousins & Huffman, 2002). 
 
Mountain gorillas living in the Virunga volcano 
range travel periodically to the upper slopes 
around 1,100-3,200 meters above sea level.  At 
these heights, they feed on species of giant 
Lobelia (Campanlaceae) and Senecio 
(Compositae), both of which are important 
plants in ethnomedicine.   
 
All members of the genus Lobelia contain 
alkaloids (iobeline, iobelanidine and 
norlobelanidine), which have a long lasting 
stimulatory effect of up to 15 minutes when 
ingested.  Higher doses can have narcotic 
effects. Indigenous peoples of the New World 
use many species of Lobelia as treatment and 
inebriates.  Gorillas reportedly feed on L. 
giberroa and L. wallastonii only occasionally 
(Cousins & Huffman, 2002). 
 
2.4. Antibiotic properties 
 
Many primates feed on figs and many Ficus spp. 
are known to contain anti-parasitic activity. 
Clinical trials on both humans and non-human 
animals have shown that preparations of some 
fig species are effective against nematodes such 
as Ascaris and Trichuris.   Ficin, a proteolytic 
enzyme is present in all fig trees, and is known 
to be an active ingredient.  Even a low 
concentrations of around 0.05% of Ficus 
glabrata latex has been shown to destroy the 
cuticle of Ascarid helminths and cause related 
lethal changes to the parasite’s body (Huffman, 
1997). 
 
Pith and fruit of species of the wild ginger 
(Afromomum) are frequently eaten by primates.  
From the literature on Afromomum species eaten 
by gorillas, significant bactericidal activities 
against Escheria coli, Pseudomonas aeruginosa, 
Yersinia entercolitica, Bacillus subtilis, Proteus 
vulgaris, Klebsiella pneumoniae and Serratia 
marcescens.  Fungicidal activities inhibited 
Candida albicans, Trichophyton 
mentagrophytes, Aspergillus niger, 
Botryodiplodis theobromae and species of 
Cladasporium cladosporiodes were found 
(Huffman, 1997).  
  
Timothy Jones argues that the herbal medicines 
and modern pharmaceuticals used by today have 
replaced the non-nutritive chemicals typically 
present in the diets of animals in the wild (Johns, 
1990).  As governments in the industrial world 
come to realize the economic benefits and 
conventional wisdom of investing in disease 
prevention, a growing market has begun to 
develop, to promote health through dietary 
supplements (nutriceuticals). 
 
 
3. THERAPEUTIC SELF MEDICATIVE 
BEHAVIOR 
 
3.1. Ape self-medication 
 
Two forms of therapeutic behavior have 
received the most attention in the field of animal 
self-medication.  They are bitter pith chewing 
and leaf swallowing.  To date, among primates 
the two parasites associated with both bitter pith 
chewing and leaf swallowing are the nodular 
worm (Oesophagostomum stephanastomum; 
Figure 1) and the tapeworm (Bertiella studeri).  
The nodular worm is perhaps one of the most 
hazardous species found in the great apes 
(Huffman, 1997).   
 
Repeated infection, which is quite common in 
the wild, causes significant complications 
including secondary bacterial infection, 
diarrhea, severe abdominal pain, weight loss, 
and weakness, which can result in death.   
 
The deleterious affects of the tapeworm are not 
well documented, but abdominal pain is 
presumed to be associated with heavy infections 
(Huffman, 1997). 
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Figure 1. Chimpanzee self-medication. a). 
chimpanzees feeding on figs in the Mahale 
Mountains National Park, Tanzania., b). adult 
male chewing  on bitter pith of Vernonia 
amygdalina, c). vernonioside B1, most bioactive 
of the vernoniosides isolated from V. 
amygdalina pith, d). adult worm of 
Oesophogostomum stephanostomum and 
Anilema acquinoctial, a species of leaf 
swallowed whole by African apes, e). adult male 
swallowing the leaves of Aspilia 
mossambicensis, f). SEM image of the surface 
of Lippia plicata, a species swallowed whole by 
chimpanzees. 
 
3.2. Bitter Pith Chewing 
 
Bitter pith chewing is proposed to aid in the 
control of nodule worm infection, via 
pharmacological action, and relief from 
gastrointestinal upset.  The hypothesis that bitter 
pith chewing has medicinal value for 
chimpanzees was first proposed from detailed 
behavioral observations, and parasitological and 
phytochemical analyses of patently ill 
chimpanzees ingesting Vernonia amygdalina 
(Compositae), and recovering from their 
symptoms within 20 hours (Huffman & Seifu, 
1989; Huffman et al., 1993). 
   
Inside Mahale M group’s home range, where 
this behavior was first documented, V. 
amygdalina is neither abundant nor evenly 
distributed throughout their territory (Huffman 
& Seifu, 1998).  Use by chimpanzees of this 
plant often requires a detour from the group’s 
commonly used travel routes.  When ingesting 
the pith from younger fleshy shoots of V. 
amygdalina, chimpanzees carefully remove the 
bark and leaves, then chew on the inner pith, 
extracting only the extremely bitter juice and 
only small amounts of fiber (Figure 1).  The 
amount of pith taken at one time is insignificant 
from a nutritional perspective; portions ranging 
from 5 to 120 cm X 1 cm.  Altogether, depending 
on the number of leaves ingested, this act takes 
anywhere from less than 1 to 8 minutes, and 
bitter pith chewing appears to be a one-dose 
treatment. Individuals have not been seen to 
chew bitter pith again within the same day or 
even within the same week.  This might possibly 
be due to the plant’s toxicity.  Adult 
chimpanzees in proximity to a sick individual 
chewing Vernonia bitter pith very rarely show 
interest in ingesting the pith themselves.  On the 
other hand, infants of ill mothers are known to 
taste small amounts of the pith discarded by their 
mothers.  Despite a year round availability of the 
plant, use of this pith by chimpanzees is highly 
seasonal and rare, occurring most frequently 
during the rainy season peak in nodule worm 
infections - as expected for a therapeutic 
treatment (Huffman & Seifu, 1998; Huffman et 
al., 1993).   
 
A noticeable drop in appetite, malaise, diarrhea 
or constipation and high levels of nodule worm 
infection characterized the condition of the 
individuals observed engaging in bitter pith 
chewing.  Marked recovery from these 
symptoms occured within 20-24 hr after pith 
chewing.   In one case, the nodular worm eggs 
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per gram feces level (EPG, a relative measure of 
the intensity of an infection) were measured and 
found to have dropped from an EPG count of 
130 to 15 within 20 hours (Huffman et al., 
1993).  
 
Ethnic groups across Africa prepare a 
concoction made from V. amygdalina leaves or 
bark, and prescribe treatment for malarial fever, 
schistosomiasis, amoebic dysentery, several 
other intestinal parasites and stomachaches 
(Huffman et al., 1996). The above noted 
recovery time of 20-24 hours after bitter-pith 
chewing in two M group chimpanzees is 
comparable to that of local human inhabitants of 
this region, the WaTongwe, who use cold water 
concoctions of the leaves as a treatment for 
parasites, diarrhea and stomach upset (Huffman 
& Seifu, 1989).   
 
Also phytochemical analysis back in the 
laboratory revealed the presence of two major 
classes of bioactive compounds; 4 sesquiterpene 
lactones and 7 new stigmastane-type steroid 
glucosides, and 2 freely occurring aglycones of 
these glucosides (Ohigashi et al., 1994).   
 
The sesquiterpene lactones are well known for 
their anthelmintic, antiamoebic, antitumor, and 
antibiotic properties.  From crude methanol 
extracts of the leaves, inhibition of tumor 
promotion and immunosuppressive activities 
have also been identified.  In vitro tests on the 
antischistosomal activity of the pith's most 
abundant steroid glucoside (vernonioside B1; 
Figure 1) and sesquiterpene lactone 
(vernodaline) showed significant inhibition of 
movement of all adult stage parasites and of 
adult females’ egg-laying capacity (Ohigashi et 
al., 1994).   
 
Together, the evidence gathered from research at 
Mahale derived from behavioral, 
parasitological, pharmacological and 
ethnomedicinal studies lend strong support to 
the hypothesis that bitter pith chewing is a 
therapeutic form of self-medication stimulated 
by, and controlling parasite infection. 
3.3. Leaf-swallowing 
 
Leaf-swallowing behavior in the African great 
apes was first reported for chimpanzees at 
Gombe and Mahale by Richard Wrangham and 
Toshida Nishida (Huffman, 2015b).  It came to 
their attention that leaf-swallowing was unlikely 
to provide any nutritional value after they found 
the folded, whole and undigested leaves of 
Aspilia mossambicensis (Compositae), A. 
pluriseta, and A. rudis in the feces of 
chimpanzees.  The interest generated in this 
behavior stimulated many field researchers to 
look for leaf swallowing at their ape study sites. 
 
To date, leaf-swallowing has been observed in 
multiple populations of chimpanzee (Pan 
troglodytes schweinfurthii, P.t. troglodytes, 
P.t.verus), bonobo (P. paniscus) and eastern 
lowland gorilla (Gorilla gorilla graueri) across 
Africa (Figure 2).  Very recently the behavior 
has also been reported for the first time in an 
Asian ape species, the white-handed gibbons 
(Hylobates lar) in Khao Yai National Park, 
Thailand (Barelli & Huffman, 2016).  In all plant 
species used by these African and Asian apes, 
the leaf surface shares the common property of 
being rough-surfaced, covered in stiff hairs or 
trichomes (Figure 1).  These abrasive hairs are 
made of silicates that are difficult to digest; a 
defense strategy of plants to inhibit over eating 
by herbivores.  
  
 
Figure 2.  Study sites across Africa where apes 
are currently known to self-medicate with either 
bitter pith chewing and or whole leaf 
swallowing. 
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Leaf-swallowing has been shown to reduce 
nodule worm infection, and possibly relieve pain 
caused by tapeworm infection, by expelling 
these two intestinal parasite species from 
chimpanzees (Huffman & Caton, 2001).  The 
demonstrated mode of parasite infection control 
is a physical mechanism that expels parasites by 
a self-induced increase in gut motility that acts 
as a purge.  The behavior is easy to distinguish 
from normal consumption of leafy material.  The 
distal half of a leaf is selected one at a time, 
folded by tongue and palate while slowly pulling 
it into the mouth.  Each leaf is individually 
swallowed whole without chewing (Figure 1).  
The leaves’ roughness makes them difficult to 
swallow, so folding them with the tongue and 
palate before swallowing is a necessary part of 
ingestion, and is responsible for their exiting 
totally undigested.  
  
At one sitting taking from one to 15 minutes or 
more, an individual can swallow anywhere from 
1 to 100 leaves.  Unlike bitter pith chewing, an 
individual may swallow leaves more than once 
in a day and over several consecutive days.  
Chimpanzees will often swallow leaves within 
the first few hours after leaving their sleeping 
nests before the first meal and or on a relatively 
empty stomach.  This timing is thought to be 
most important for the behavior to be effective 
(Huffman & Caton, 2001).  At Mahale, Gombe, 
Kibale, Lomako (DR Congo) and Fongoli 
(Senegal) where longitudinal studies have now 
been conducted, leaf swallowing is shown to 
occur widely across the distribution of African 
great apes (Figure 1). 
 
 
4. THE FUTURE 
 
Much remains to be learned about the self-
medicative behavior of animals, as there are still 
so many species unexplored, but as shown 
above, reoccurring patterns of the type of 
behavior and the kinds of parasites associated 
with them emerge.  With time and diligent 
research I think the future will bring us many 
new discoveries.  We stand to gain not only 
knowledge about future medicines for 
humankind, but have the chance to use this 
knowledge to convince others that the natural 
world is worth preserving, and the creatures that 
we share this planet with have much knowledge 
to yet to share with us and must be allowed to 
live their lives in peace. 
 
Sabbe Satta Bhavantu Sukhitatta. 
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